BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Zheng H, Wu R, Kosten TR, Zhang X, Zhao J. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. Schizophrenia Research 2019;212:92-8. [DOI: 10.1016/j.schres.2019.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Patlola SR, Donohoe G, Mckernan DP. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023;121:110668. [DOI: 10.1016/j.pnpbp.2022.110668] [Reference Citation Analysis]
2 Khan MM. Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options. Neuroscience & Biobehavioral Reviews 2022;143:104919. [DOI: 10.1016/j.neubiorev.2022.104919] [Reference Citation Analysis]
3 Morén C, Treder N, Martínez-pinteño A, Rodríguez N, Arbelo N, Madero S, Gómez M, Mas S, Gassó P, Parellada E. Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia. Antioxidants 2022;11:2275. [DOI: 10.3390/antiox11112275] [Reference Citation Analysis]
4 Wang Y, Meng W, Liu Z, An Q, Hu X. Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1046692] [Reference Citation Analysis]
5 Lombardo G, Nettis MA, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Worrell C, Enache D, Mclaughlin A, Kose M, Bogdanova A, Sforzini L, Cleare AJ, Young AH, Mondelli V, Pariante CM. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100561] [Reference Citation Analysis]
6 Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-levy U, Lotan A, Lerer B. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Mol Psychiatry 2022. [DOI: 10.1038/s41380-022-01832-z] [Reference Citation Analysis]
7 Maroney M. Management of cognitive and negative symptoms in schizophrenia. Mental Health Clinician 2022;12:282-299. [DOI: 10.9740/mhc.2022.10.282] [Reference Citation Analysis]
8 Zhao F, Li B, Yang W, Ge T, Cui R. Brain-immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders. Cell Prolif 2022;:e13295. [PMID: 35860850 DOI: 10.1111/cpr.13295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wegrzyn D, Juckel G, Faissner A. Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models. Int J Mol Sci 2022;23:5482. [PMID: 35628292 DOI: 10.3390/ijms23105482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Morrens M, Overloop C, Coppens V, Loots E, Van Den Noortgate M, Vandenameele S, Leboyer M, De Picker L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatry 2022. [PMID: 35484245 DOI: 10.1038/s41380-022-01582-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Motaghinejad M, Motevalian M. Neuroprotective Properties of Minocycline Against Methylphenidate-Induced Neurodegeneration: Possible Role of CREB/BDNF and Akt/GSK3 Signaling Pathways in Rat Hippocampus. Neurotox Res 2022. [PMID: 35446003 DOI: 10.1007/s12640-021-00454-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bishop JR, Zhang L, Lizano P. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies. Harv Rev Psychiatry 2022;30:59-70. [PMID: 34995036 DOI: 10.1097/HRP.0000000000000321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
13 Kumar M, Arora P, Sandhir R. Biphasic Role of Microglia in Healthy and Diseased Brain. The Biology of Glial Cells: Recent Advances 2022. [DOI: 10.1007/978-981-16-8313-8_18] [Reference Citation Analysis]
14 Ma J, Zhang Y, Huang Z, Liu X, Lv L, Li Y. Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine. Front Psychiatry 2021;12:782289. [PMID: 34955927 DOI: 10.3389/fpsyt.2021.782289] [Reference Citation Analysis]
15 Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? Postgrad Med 2021;:1-13. [PMID: 34766870 DOI: 10.1080/00325481.2021.2006514] [Reference Citation Analysis]
16 Upthegrove R, Deakin B. Effectiveness of Immunotherapies for Psychotic Disorders. Textbook of Immunopsychiatry 2021. [DOI: 10.1017/9781108539623.007] [Reference Citation Analysis]
17 Martínez AL, Brea J, Rico S, de Los Frailes MT, Loza MI. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments. Int J Mol Sci 2021;22:9905. [PMID: 34576069 DOI: 10.3390/ijms22189905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
18 Romero-Miguel D, Casquero-Veiga M, MacDowell KS, Torres-Sanchez S, Garcia-Partida JA, Lamanna-Rama N, Romero-Miranda A, Berrocoso E, Leza JC, Desco M, Soto-Montenegro ML. A characterization of the effects of minocycline treatment during adolescence on structural, metabolic and oxidative stress parameters in a maternal immune stimulation model of neurodevelopmental brain disorders. Int J Neuropsychopharmacol 2021:pyab036. [PMID: 34165516 DOI: 10.1093/ijnp/pyab036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Front Neurol 2021;12:636139. [PMID: 34239490 DOI: 10.3389/fneur.2021.636139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ahmed A, Misrani A, Tabassum S, Yang L, Long C. Minocycline inhibits sleep deprivation-induced aberrant microglial activation and Keap1-Nrf2 expression in mouse hippocampus. Brain Res Bull 2021;174:41-52. [PMID: 34087360 DOI: 10.1016/j.brainresbull.2021.05.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Izuo N, Nitta A. New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction. J Pers Med 2021;11:371. [PMID: 34063598 DOI: 10.3390/jpm11050371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mehta UM, Keshavan MS. Hindsight 2020: Emerging research trends in schizophrenia. Schizophr Res 2021;229:22-4. [PMID: 33609986 DOI: 10.1016/j.schres.2021.01.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Germann M, Brederoo SG, Sommer IEC. Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders. Curr Opin Psychiatry 2021;34:222-7. [PMID: 33560023 DOI: 10.1097/YCO.0000000000000696] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
24 Romero-Miguel D, Lamanna-Rama N, Casquero-Veiga M, Gómez-Rangel V, Desco M, Soto-Montenegro ML. Minocycline in neurodegenerative and psychiatric diseases: An update. Eur J Neurol 2021;28:1056-81. [PMID: 33180965 DOI: 10.1111/ene.14642] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
25 Miller BJ, Goldsmith DR. Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder. Focus (Am Psychiatr Publ) 2020;18:391-401. [PMID: 33343251 DOI: 10.1176/appi.focus.20200015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Miyanishi K, Sato A, Kihara N, Utsunomiya R, Tanaka J. Synaptic elimination by microglia and disturbed higher brain functions. Neurochem Int 2021;142:104901. [PMID: 33181238 DOI: 10.1016/j.neuint.2020.104901] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
27 Cha HY, Yang SJ. Anti-Inflammatory Diets and Schizophrenia.Clin Nutr Res. 2020;9:241-257. [PMID: 33204665 DOI: 10.7762/cnr.2020.9.4.241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
28 Issy AC, Pedrazzi JFC, van Oosten ABS, Checheto T, Silva RR, Noël F, Del-Bel E. Effects of Doxycycline in Swiss Mice Predictive Models of Schizophrenia. Neurotox Res 2020;38:1049-60. [PMID: 32929685 DOI: 10.1007/s12640-020-00268-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Jeppesen R, Christensen RHB, Pedersen EMJ, Nordentoft M, Hjorthøj C, Köhler-Forsberg O, Benros ME. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis. Brain Behav Immun 2020;90:364-80. [PMID: 32890697 DOI: 10.1016/j.bbi.2020.08.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
30 Dai N, Jie H, Duan Y, Xiong P, Xu X, Chen P, Kang M, Li M, Li T, Huang Z, Chen H. Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms. Psychiatry Clin Neurosci 2020;74:472-9. [PMID: 32478952 DOI: 10.1111/pcn.13078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
31 Zhou J, Yang J, Dai M, Lin D, Zhang R, Liu H, Yu A, Vakal S, Wang Y, Li X. A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis. Biochem Pharmacol 2020;180:114108. [PMID: 32569628 DOI: 10.1016/j.bcp.2020.114108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ding X, Yang W, Ren Q, Hu J, Yang S, Han W, Wang J, Wang X, Wang H. Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma. J Neuroinflammation 2020;17:190. [PMID: 32546235 DOI: 10.1186/s12974-020-01839-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Miller BJ, Herzig KH, Jokelainen J, Karhu T, Keinänen-Kiukaanniemi S, Järvelin MR, Veijola J, Viinamäki H, Päivikki Tanskanen, Jääskeläinen E, Isohanni M, Timonen M. Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966. Eur Arch Psychiatry Clin Neurosci 2021;271:609-22. [PMID: 32382794 DOI: 10.1007/s00406-020-01134-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]